# Intranasal Lidocaine for Prevention of Postoperative Nausea and Vomiting.

> **NCT04810494** · PHASE4 · WITHDRAWN · sponsor: **Milton S. Hershey Medical Center**

## Conditions studied

- Postoperative Nausea and Vomiting

## Interventions

- **DRUG:** 2% Lidocaine HCl topical solution
- **DRUG:** 0.9% Sodium chloride

## Key facts

- **NCT ID:** NCT04810494
- **Lead sponsor:** Milton S. Hershey Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2022-10-01
- **Primary completion:** 2023-03-31
- **Final completion:** 2023-06-30
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Change in study team
- **Last updated:** 2022-12-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04810494

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04810494, "Intranasal Lidocaine for Prevention of Postoperative Nausea and Vomiting.". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT04810494. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*